Translation: its less that your cells break, and more that theyre running on a smaller battery
It slows the emptying of your stomach, helping you feel fuller longer and decreasing overall calorie intake
We recently wrote about the practice of microdosing GLP-1 drugs like Ozempic, which are used to manage Type 2 diabetes
Its regulatory journey includes the TRANSCEND-T2D Phase 3 clinical trial program, launched in 2024, which is critical for evaluating its efficacy and safety
The prices are going down, Lilly and NovoNordisk have expanded their direct-to-consumer marketing and seem to have reduced their efforts to litigate against compounding pharmacies that supply compounded GLP-1s
These practices may seem small, but they can have a measurable effect on how you feel